Search Results - "Perdek, N."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.

    Authors: Rammant, E. Fox, L. Beyer, K. et al.

    Source: Quality of Life Research. Aug2023, Vol. 32 Issue 8, p2127-2135. 9p. 1 Diagram, 1 Chart.

    Subjects: Quality of life, Bladder cancer, Cancer patients, Psychometrics, Data extraction, Urological surgery, Classical test theory

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.

    Authors: Vivaldi G Jolliffe DA Faustini S et al.

    Source: The Journal of infectious diseases [J Infect Dis] 2022 Nov 28; Vol. 226 (11), pp. 1903-1908.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK).

    Authors: Jolliffe DA Faustini SE Holt H et al.

    Source: Vaccines [Vaccines (Basel)] 2022 Sep 23; Vol. 10 (10). Date of Electronic Publication: 2022 Sep 23.

    Publication Type: Journal Article

    Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK).

    Authors: Talaei M Faustini S Holt H et al.

    Source: BMC medicine [BMC Med] 2022 Feb 22; Vol. 20 (1), pp. 87. Date of Electronic Publication: 2022 Feb 22.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    Influence of individuals' determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination.

    Authors: Chambers ES Cai W Vivaldi G et al.

    Source: NPJ vaccines [NPJ Vaccines] 2024 May 22; Vol. 9 (1), pp. 87. Date of Electronic Publication: 2024 May 22.

    Publication Type: Journal Article

    Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE

    Save to List
  6. 6

    Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflict.

    Authors: Van Hemelrijck M Fox L Beyer K et al.

    Source: Journal of cancer policy [J Cancer Policy] 2022 Dec; Vol. 34, pp. 100370. Date of Electronic Publication: 2022 Nov 12.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101639933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-5383 (Electronic) Linking ISSN: 22135383 NLM ISO Abbreviation: J Cancer Policy Subsets: MEDLINE

    Save to List
  7. 7

    Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT).

    Authors: Jolliffe DA Holt H Greenig M et al.

    Source: BMJ (Clinical research ed.) [BMJ] 2022 Sep 07; Vol. 378, pp. e071230. Date of Electronic Publication: 2022 Sep 07.

    Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

    Journal Info: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

    Save to List

Search Tools: